Sonnet BioTherapeutics Holdings logo
Sonnet BioTherapeutics Holdings SONN
€ 2.76 -0.34%

Quartalsbericht 2024-Q2
hinzugefügt 14.08.2024

report update icon

Sonnet BioTherapeutics Holdings Kennzahlen 2011-2024 | SONN

Kennzahlen Jährlich Sonnet BioTherapeutics Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.0 - -1.0 -0.8 -1.0 -1.4 -1.1 -0.8 -462.8 -872.9 -630.7 -

P/S

11.2 0.5 - - - 0.2 0.2 0.2 0.3 99.3 551.9 226673.6 -

EPS

-18.1 -150.5 -14.2 -7.0 -2.6 -2.0 -2.7 -4.2 -0.9 -0.9 -1.2 -1.2 -1.0

EV (Enterprise Value)

5.02 M 5.51 M -20.9 M 22.8 M 6.29 M 28.6 M 29 M 29.8 M 29.3 M 2.98 B 4.56 B 734 M 4.16 M

EBITDA per Share

-18.1 -150 -14.3 -2.57 -22.9 -26.2 -31.4 -3.33 -67.5 -0.389 -0.783 -0.71 -

EV/EBITDA

0.8 -0.7 -0.8 -3.7 -4.4 -48.5 -2.6 -1204.2 -1332.0 -870.4 -1.2

PEG

-0.0 -0.0 - -0.01 -0.02 -0.04 -0.04 -0.02 0.0 -30.17 40.17 6.83 -

P/B

-7.4 -0.1 - 8.3 -1.4 0.9 0.9 0.7 0.5 197.9 405.0 132.6 -

P/CF

-0.1 -0.0 - 139.9 -1.8 -2.4 -4.2 -5.6 -1.4 -988.9 -715.4 -532.7 -

ROE %

8333.79 1170.74 -112.24 -803.50 171.19 -92.25 -63.46 -70.29 -56.80 -42.77 -46.39 -21.03 -208.24

ROA %

-346.86 -509.81 -86.17 -303.53 -12253.39 -23.01 -22.51 -27.11 -28.76 -17.89 -25.96 -15.21 -21.08

ROCE %

8316.05 1168.67 -112.70 -741.23 165.47 -32.02 -34.89 -12.26 -20.73 -22.74 -31.65 -16.27 -93.82

Current Ratio

1.0 0.7 4.3 1.6 0.0 0.1 0.1 0.1 0.2 0.1 0.3 1.1 0.2

DSO

- - - - - 3.9 4.2 4.6 9.6 3.4 10.1 18173.6 343.7

DIO

- - - - - 4.4 4.5 5.5 8.4 366.9 - - -

DPO

- - - - - - - - - 3843.1 - - -

Betriebszyklus

- - - - - 8.2 8.7 10.1 18.0 370.3 - - -

Finanzkreislauf

- - - - - 8.2 8.7 10.1 18.0 -3472.8 - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Sonnet BioTherapeutics Holdings

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.7 0.08 -0.31 - -2.95 -7.55 -17.62 -0.37 -1.82 -1.91 -1.44 -0.93 -0.27 -0.32 -0.34 -2.23 -1.05 -0.34 -0.44 -0.39 -0.26 -13.28 - -0.34 -0.23 -0.83 - -0.7 -0.81 -0.79 - -0.41 -2.35 -0.07 - -0.31 -0.24 -0.27 - -0.52 -0.07 -0.24 - -0.38 -0.19 -0.2 - -0.2 -0.56 -0.28 - -0.4 -0.18 0.11

EBITDA per Share

- - -0.34 - - - -17.8 -4.02 -1.82 -1.91 -1.44 -0.93 -0.28 -0.32 -0.34 -2.23 -1.04 -0.32 -0.44 -0.37 -0.16 -8.63 - -0.04 0.03 -0.58 - -0.33 -0.2 -0.18 - 0.03 0.03 -0.02 - -0.05 -0.11 -0.23 - -0.01 -0.02 -0.26 - -0.16 -0.12 -0.18 - -0.13 -0.31 -0.17 - -0.22 -0.18 0.11

ROE %

-282.81 -264.37 -381.89 -64.33 813.53 -101.76 -92.40 -286.91 -1245.78 -661.87 -864.30 -590.17 -272.87 410.26 945.17 811.78 662.26 402.42 173.99 67.16 -36.27 -22.96 -65.78 -77.83 -77.15 -85.10 -50.29 -57.49 -48.71 -70.74 -58.76 -79.52 -93.08 -69.21 -47.53 -51.21 -34.13 -21.33 -16.85 -32.32 -44.10 -46.84 -28.32 -41.70 -39.62 -48.59 -41.37 -143.43 -232.10 -263.36 -102.11 -102.06 -46.52 46.46

ROA %

-115.51 -94.37 -143.13 -194.03 -576.30 -642.14 -654.12 -571.90 -251.82 -231.87 -198.14 -362.03 -373.35 -361.64 -414.33 -228.38 -6365.70 -6295.30 -6222.37 -6215.52 -8.84 -8.28 -16.41 -21.09 -22.61 -26.50 -17.84 -20.54 -17.57 -26.21 -22.05 -32.75 -40.75 -34.09 -24.50 -26.04 -16.88 -10.00 -7.13 -14.22 -19.77 -21.74 -14.28 -23.95 -26.54 -34.06 -29.91 -40.24 -40.90 -34.58 -10.34 -10.33 -4.71 4.70

ROCE %

-425.69 -405.44 -384.30 -61.38 816.71 -98.22 -88.92 -285.50 -1245.09 -671.52 -873.83 -600.15 154.63 1083.59 1617.88 1485.01 960.50 464.09 275.31 163.37 5.56 23.25 -46.73 -59.79 -63.82 -68.27 -32.40 -36.52 -27.58 -21.60 -15.45 -20.43 -21.29 -24.46 -21.02 -24.57 -23.14 -19.27 -17.49 -28.09 -35.15 -37.84 -23.62 -37.39 -40.56 -45.89 -34.43 -93.34 -138.48 -174.26 -62.03 -58.91 -47.23 44.12

Current Ratio

1.8 2.1 1.9 1.0 1.5 1.7 0.6 0.7 1.1 2.3 4.8 4.3 1.2 4.3 0.6 1.6 1.6 1.6 0.9 0.0 1.2 1.2 1.4 1.4 1.4 1.4 1.6 1.6 1.6 1.6 1.7 1.7 1.7 1.7 2.1 2.1 2.1 2.1 1.7 1.7 1.7 1.7 2.3 2.3 2.3 2.3 3.6 3.6 3.6 3.6 1.1 1.1 1.1 1.1

DSO

- - - - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

Finanzkreislauf

- - - - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

Alle Zahlen in USD-Währung